SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071279
Filing Date
2022-11-10
Accepted
2022-11-10 16:57:54
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_hoththerap.htm   iXBRL 10-Q 599688
2 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND STEFANIE f10q0922ex10-1_hoththerap.htm EX-10.1 38775
3 CERTIFICATION f10q0922ex31-1_hoththerap.htm EX-31.1 10116
4 CERTIFICATION f10q0922ex31-2_hoththerap.htm EX-31.2 10135
5 CERTIFICATION f10q0922ex32-1_hoththerap.htm EX-32.1 3430
6 CERTIFICATION f10q0922ex32-2_hoththerap.htm EX-32.2 3559
  Complete submission text file 0001213900-22-071279.txt   3463686

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hoth-20220930.xsd EX-101.SCH 49050
8 XBRL CALCULATION FILE hoth-20220930_cal.xml EX-101.CAL 24832
9 XBRL DEFINITION FILE hoth-20220930_def.xml EX-101.DEF 176098
10 XBRL LABEL FILE hoth-20220930_lab.xml EX-101.LAB 376130
11 XBRL PRESENTATION FILE hoth-20220930_pre.xml EX-101.PRE 191983
53 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_hoththerap_htm.xml XML 352413
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 221378241
SIC: 2834 Pharmaceutical Preparations